Nergiz Dagoglu

Nergiz Dagoglu

Auto-generated profile, based on publicly available information

Nergiz Dagoglu

Department of Radiation Oncology, Istanbul Faculty of Medicine, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2024 in Indian Journal of Clinical Biochemistry
Verified
Journal Article
Closed access
PDF file
TMTUGBA MEHMETOGLU-GURBUZ
TUGBA MEHMETOGLU-GURBUZ
EOEthem Nezih Oral
Ethem Nezih Oral
RSRabia Nergiz Dağoğlu Sakin
Rabia Nergiz Dağoğlu Sakin
ŞKŞule Karaman
Şule Karaman
ŞDŞermin Durak
Şermin Durak
ÜZÜmit Zeybek
Ümit Zeybek

15 July 2022 in Advances in Radiation Oncology
Verified
Journal Article
Open access
NDNergiz Dagoglu
Nergiz Dagoglu
SKSule Karaman
Sule Karaman
BABanu Atalar
Banu Atalar
RMRobert C. Miller
Robert C. Miller
EOEthem N. Oral
Ethem N. Oral
For over 10 years, the Syrian conflict has caused millions of people to leave their homeland, causing one of the biggest refugee crises in modern history. Considering its prevalence, cancer is an important care burden among Syrian refugees. Radiation therapy is one of the essential parts of cancer treatment, and radiation oncology departments must guarantee optimal cancer treatments even in such a challenging setting when patients are displaced forcefully from their homes. National and institutional measures are highlighted in this manuscript to provide suggestions for the delivery of care during refugee crises. There are two issues creating barriers to serving refugee populations: the loss of access to their original care records in Syria for those with a previous diagnosis of cancer referred for continuation of radiation therapy or reirradiation, and the effect of acute radiation therapy toxicity on treatment compliance.

21 September 2026 in Langenbeck's Archives of Surgery
Verified
Journal Article
Open access
PDF file
İÖİlgin Özden
İlgin Özden
OBOrhan Bilge
Orhan Bilge
NDNergiz Dağoğlu
Nergiz Dağoğlu
AYAyşen Yavru
Ayşen Yavru
MGMine Güllüoğlu
Mine Güllüoğlu
AKAhmet Kızir
Ahmet Kızir

1 September 2022 in Journal of Surgery and Medicine
Verified
Journal Article
Open access
PDF file
ŞKŞule Karaman
Şule Karaman
SÖSeda Güler Özben
Seda Güler Özben
NKNazmiye Dönmez Kesen
Nazmiye Dönmez Kesen
ÖKÖzge Karaçay
Özge Karaçay
NSNergiz Dağoğlu Sakin
Nergiz Dağoğlu Sakin
YDYavuz Dizdar
Yavuz Dizdar
Background/Aim: Previous studies on fractionation in radiation therapy have been mainly based on applying equal doses over at least 6 h. The main purpose of fractionation is to increase normal tissue tolerance rather than tumor sensitivity. Thus, one can apply higher doses to the tumor. In contrast, new molecular studies indicate that high and low doses of radiation act by different mechanisms. This study was conducted to investigate the radiobiological effect of asymmetrical radiation doses. Methods: This is an experimental study done in vitro with a G6 glioma cell line to investigate the responses when C6 glioma cells are irradiated with single doses of 30 and 230 cGy using an orthovoltage therapy device or doses split into 30 and 200 and 115 and 115 cGy within periods of 15 and 30 min. A total of 5 × 103 cells were transferred to polyethylene culture flasks for colony formation. A cluster containing more than 30 cells was considered a new colony. Results: A single dose of 230 cGy caused a 56.8% reduction in colony formation. However, when 230 cGy was divided over 15- and 30-min periods in fractions of 30 and 200 cGy, colony formation was significantly reduced compared to the control group (68.13% and 52.64%, P = 0.030, respectively). This effect continued when the radiation dose was divided into equal fractions (115 and 115 cGy) with periods of 15 and 30 min (42.60%, P = 0.021 and 20.77%, P = 0.008, respectively). Conclusion: According to these results, (i) short interval (15 and 30 min) fractionation significantly reduces colony formation compared to a single equal dose; and (ii) the protective mechanisms activated in cell response probably vary at different radiation doses and different fractions. '+st+' Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer. 2004 Nov 17;(9):737-47. DOI: https://doi.org/10.1038/nrc1451 Holsti LR. Development of clinical radiotherapy since 1896. Acta Oncol. 1995 Jul 08;34(8):995-1003. DOI: https://doi.org/10.3109/02841869509127225 Moulder JE, Seymour C. Radiation fractionation: the search for isoeffect relationships and mechanisms. Int J Radiat Biol. 2018 Oct 02;94(8):743-51. DOI: https://doi.org/10.1080/09553002.2017.1376764 Yan W, Khan MK, Wu X, et al. Spatially fractionated radiation therapy: History, present and the future. Clin Transl Radiat Oncol. 2019 Oct 22;20:30-8. DOI: https://doi.org/10.1016/j.ctro.2019.10.004 Yin E, Nelson DO, Coleman MA, Peterson LE, Wyrobek AJ. Gene expression changes in mouse brain after exposure to low-dose ionizing radiation. Int J Radiat Biol. 2003 Jul 03;79(10):759-75. DOI: https://doi.org/10.1080/09553000310001610961 Coleman MA, Yin E, Peterson LE, et al. Low-dose irradiation alters the transcript profiles of human lymphoblastoid cells including genes associated with cytogenetic radioadaptive response. Radiat Res. 2005 Oct 01;164:369-82. DOI: https://doi.org/10.1667/RR3356.1 Park WY, Hwang CI, Im CN, et al. Identification of radiation-specific responses from gene expression profile. Oncogene. 2002 Dec 05;21(55):8521-8. DOI: https://doi.org/10.1038/sj.onc.1205977 Amundson SA, Lee RA, Koch-Paiz CA, et al. Differential responses of stress genes to low dose-rate gamma irradiation. Mol Cancer Res. 2003 Apr 01 ;1(6):445-52. Sasaki MS, Ejima Y, Tachibana A, et al. DNA damage response pathway in radioadaptive response. Mutat Res. 2002 Jul 25;504(1-2):101-18. DOI: https://doi.org/10.1016/S0027-5107(02)00084-2 Tomascik-Cheeseman LM, Coleman MA, Marchetti F, et al. Differential basal expression of genes associated with stress response, damage control, and DNA repair among mouse tissues. Mutat Res. 2004 Jul 11;561(1-2):1-14. DOI: https://doi.org/10.1016/j.mrgentox.2004.02.011 Ikushima T. Chromosomal responses to ionizing radiation reminiscent of an adaptive response in cultured Chinese hamster cells. Mutat Res. 1987 Oct 01;180(2):215-21. DOI: https://doi.org/10.1016/0027-5107(87)90217-X Ojima M, Ishii K, Hayashi T, Ito A. Induction of radio-adaptive response in colony formation by low dose X-ray irradiation. Physiol Chem Phys Med NMR. 2001 Mar 25;33(1):41-48. Chendil D, Das A, Dey S, Mohiuddin M, Ahmed MM. Par-4, a pro-apoptotic gene, inhibits radiation-induced NF kappa B activity and Bcl-2 expression leading to induction of radiosensitivity in human prostate cancer cells PC-3. Cancer Biol Ther. 2002 Jan 07;1(2):152-60. DOI: https://doi.org/10.4161/cbt.61 Yang G, Li W, Jiang H, et al. Low-dose radiation may be a novel approach to enhance the effectiveness of cancer therapeutics. Int J Cancer. 2016 Nov 15;139(10):2157-68. DOI: https://doi.org/10.1002/ijc.30235 Ozmen T, Oktem G, Tuna S, et al. Different doses of radiation on agar colony forming development in C6 glioma cells: Assessment by thymidine labeling index, and bromodeoxyuridine labeling index. Turkey Clinic J Med Sci 2007 May 01; 27:321-7. Bilge H. Beam characteristics of kilovoltage radiotherapy unit. J BUON. 2004 Jul 01;9(3):303-6. Williams MV, Denekamp J, Fowler JF. A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys. 1985 Jan 01;11(1):87-96. DOI: https://doi.org/10.1016/0360-3016(85)90366-9 Withers HR. Cell cycle redistribution as a factor in multifraction irradiation. Radiology. 1975 Jan 01;114(1):199-202. DOI: https://doi.org/10.1148/114.1.199 Elkind MM, Sutton H. Radiation response of mammalian cells grown in culture. 1. Repair of X-ray damage in surviving Chinese hamster cells. Radiat Res. 1960 Oct 01;13:556-93. DOI: https://doi.org/10.2307/3570945 Hauptmann M, Haghdoost S, Gomolka M, et al. Differential Response and Priming Dose Effect on the Proteome of Human Fibroblast and Stem Cells Induced by Exposure to Low Doses of Ionizing Radiation. Radiat Res. 2016 Mar 01;185(3):299-312. DOI:...

2 July 2019
Verified
Book Chapter
Closed access
PDF file
NDNergiz Dagoglu
Nergiz Dagoglu
AMAnand Mahadevan
Anand Mahadevan

Verified
Journal Article
Open access
PDF file
HSHilal Oguz soydinc
Hilal Oguz soydinc
MSMurat Serilmez
Murat Serilmez
CYCeren Tilgen Yasasever
Ceren Tilgen Yasasever
EDElif Bilgin Doğru
Elif Bilgin Doğru
UGUgur Gezer
Ugur Gezer
DDDerya Duranyıldız
Derya Duranyıldız
Non-small cell lung cancer remains one of the leading causes of cancer-related mortality worldwide, and identifying molecular markers associated with tumor progression and metastasis is important for improving patient management. This study investigated serum ELMO-3 levels in patients with NSCLC and evaluated their relationship with clinicopathological characteristics. Serum samples from 50 NSCLC patients and 20 healthy controls were analyzed. ELMO-3 concentrations were measured using an enzyme-linked immunosorbent assay. Statistical analyses included non-parametric group comparisons, receiver operating characteristic curve analysis, Kaplan–Meier survival analysis, and multivariate Cox proportional hazards regression. The mean ELMO-3 level was 0.409 ± 0.543, which was used as the cutoff value to categorize patients into low- and high-ELMO-3 groups; 76% of patients were classified as low-ELMO-3 and 24% as high-ELMO-3. The results showed that serum ELMO-3 levels did not differ significantly between NSCLC patients and healthy controls and were not associated with metastatic status. However, a significant association was observed between ELMO-3 expression status and tumor histopathology. Survival analysis demonstrated that distant metastasis and radiotherapy were significantly associated with overall survival. In multivariate analysis, age, operability, distant metastasis, and serum ELMO-3 levels were identified as independent factors associated with survival. These findings suggest that circulating ELMO-3 may have potential prognostic relevance; however, the results should be interpreted with caution and require validation in larger, independent cohorts.